Welcome to our dedicated page for Owlet news (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet stock.
Owlet Inc (OWLT) delivers innovative digital parenting solutions through smart baby monitors and health-tracking wearables. This news hub provides investors and caregivers with essential updates on the company’s advancements in infant care technology.
Access real-time information on product launches, financial results, and strategic partnerships directly from official sources. Our curated collection includes press releases, regulatory filings, and market developments relevant to Owlet’s IoT-enabled ecosystem.
Key updates cover earnings announcements, FDA clearances for medical devices, retail expansions, and sleep solution program enhancements. Stay informed about innovations in wearable vitals monitoring and cloud-based parenting platforms that define Owlet’s market position.
Bookmark this page for streamlined access to verified OWLT updates. Combine ongoing monitoring with historical context to track the company’s progress in transforming infant care through connected devices.
Owlet, a leader in smart infant monitoring, has achieved UKCA certification for its Dream Sock, a significant milestone following its recent CE Mark certification. This recognition allows Owlet to expand its reach across the UK and Europe, where it already has key retail partnerships. The Dream Sock, designed for healthy infants, measures oxygen saturation, pulse rate, and provides sleep insights. It will soon be available at major retailers in the UK, Germany, and France, and later in other European countries. This expansion is poised to impact over 3.8 million annual births in the region.
Owlet, Inc. announced strong first quarter 2024 results with revenue of approximately $14.8 million, up 37% year over year, gross margin at 44.4%, and net income of $3.3 million. The company's adjusted EBITDA loss improved by 46% year over year. Owlet's CEO highlighted the positive feedback on their medical devices and increased demand for their products, projecting continued success in 2024.
Owlet, Inc. announces the EU medical device certification of Dream Sock, a smart infant monitoring product. This certification allows Owlet to expand its product portfolio in European markets and provide caregivers with innovative technology for home-based baby monitoring. The product offers clinically-proven accuracy and real-time data delivery through a mobile app and Base Station. Dream Sock is set to launch in Germany, France, and the UK this spring, with plans for further European expansion.
Owlet, Inc. (NYSE: OWLT), a leader in smart infant monitoring, will be participating in two upcoming investor conferences: the Emerging Growth Virtual Conference on May 8, 2024, and the Sidoti May Micro Cap Virtual Conference on May 8-9, 2024. The Company's Co-Founder and CEO, Kurt Workman, along with CFO Kate Scolnick, will present at both events.
Owlet, Inc. will announce its first quarter 2024 financial results on May 6, 2024. The company's executives will host a conference call to discuss the results and provide a business update.
FAQ
What is the current stock price of Owlet (OWLT)?
What is the market cap of Owlet (OWLT)?
